Trial Profile
A Prospective, Randomized, Double-blind, Phase II Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgeries
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Thrombin (Primary)
- Indications Surgical blood loss
- Focus Adverse reactions; Therapeutic Use
- Sponsors Grifols
- 13 Nov 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 19 Oct 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov.
- 19 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.